Login / Signup
Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment.
Hannah V Giles
Guy Pratt
Published in:
British journal of haematology (2020)
Keyphrases
</>
multiple myeloma
stem cells
signaling pathway
protein kinase
replacement therapy